Vet Med - Czech, 2025, 70(8):279-293 | DOI: 10.17221/24/2025-VETMED

Cytotoxic and apoptotic effects of etoposide and ellagic acid alone or with possible synergistic/additive combinations on a canine D-17 osteosarcoma cell lineOriginal Paper

GS Ekren Asici ORCID..., F Kiral ORCID..., A Bildik ORCID..., PA Ulutas ORCID...
Department of Biochemistry, Faculty of Veterinary Medicine, Aydin Adnan Menderes University, Aydin, Turkiye

Osteosarcoma (OSA) is the most prevalent and aggressive malignancy of canine bones. Etoposide is an effective chemotherapeutic agent for cancer treatment, whereas ellagic acid is a naturally occurring compound with antioxidant and anticancer properties; however, both are inhibitors of the topoisomerase enzyme. In this study, the synergistic/additive effect of etoposide, known to have a growth-inhibitory impact in canine osteosarcoma (OSA) cells, and ellagic acid was investigated. The mechanism by which this effect inhibits cell growth at lower etoposide doses was also examined. The IC₅₀ values of both agents were determined, and possible combination doses were generated accordingly and applied to canine OSA cells. The apoptotic effects of the combinations were evaluated based on DNA breaks and the activity levels of caspase 3, 8, and 9. These findings were supported by the expression levels of Bcl-2, Bax, and Bid genes, as well as the AO/EtBr staining method. The effects on cell cycle and proliferation were analysed through survivin and NF-κβ gene expressions. Antimetastatic effects were determined using invasion and migration assays. EA is a potential therapeutic agent for cancer treatment. In combination with ET, a higher anticancer efficacy was demonstrated compared to etoposide alone. Potential treatment side effects can be reduced by enabling the use of lower drug doses.

Keywords: acridine orange, ethidium bromide staining; Bax, Bcl-2 ratio; caspase 3, caspase 8, caspase 9

Received: April 1, 2025; Revised: July 1, 2025; Accepted: July 9, 2025; Published: August 30, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ekren Asici G, Kiral F, Bildik A, Ulutas P. Cytotoxic and apoptotic effects of etoposide and ellagic acid alone or with possible synergistic/additive combinations on a canine D-17 osteosarcoma cell line. Vet Med - Czech. 2025;70(8):279-293. doi: 10.17221/24/2025-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alfredsson CF, Ding M, Liang QL, Sundstrom BE, Nanberg E. Ellagic acid induces a dose- and time-dependent depolarization of mitochondria and activation of caspase-9 and -3 in human neuroblastoma cells. Biomed Pharmacother. 2014 Feb;68(1):129-35. Go to original source... Go to PubMed...
    2. Bender RP, Jablonksy MJ, Shadid M, Romaine I, Dunlap N, Anklin C, Graves DE, Osheroff N. Substituents on etoposide that interact with human topoisomerase II alpha in the binary enzyme-drug complex: Contributions to etoposide binding and activity. Biochemistry. 2008 Apr;47(15):4501-9. Go to original source... Go to PubMed...
    3. Bildik A, Bayar I. Kanserde apoptotik yolaklarin inhibisyonu [Inhibition of apoptotic pathways in cancer]. Turkiye Klinikleri J Vet Sci. 2018;9(2):42-51. Turkish. Go to original source...
    4. Boye P, Serres F, Marescaux L, Hordeaux J, Bouchaert E, Gomes B, Tierny D. Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma. PLoS One. 2017 May;12(5):e0177486. Go to original source... Go to PubMed...
    5. Chen G. The relationship between the expression of TAM, survivin and the degree of necrosis of the tumor after cisplatin treatment in osteosarcoma. Eur Rev Med Pharmacol Sci. 2017 Feb;21(3):490-7.
    6. Chen H, Zuo Y, Deng Y. Separation and determination of flavonoids and other phenolic compounds in cranberry juice by high-performance liquid chromatography. J Chromatogr A. 2001 Apr 13;913(1-2):387-95. Go to original source... Go to PubMed...
    7. Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010 Jan 15;70(2):440-6. Go to original source... Go to PubMed...
    8. Chung YC, Lu LC, Tsai MH, Chen YJ, Chen YY, Yao SP, Hsu CP. The inhibitory effect of ellagic Acid on cell growth of ovarian carcinoma cells. Evid Based Complement Alternat Med. 2013 Jun;2013:306705. Go to original source... Go to PubMed...
    9. Cizmarikova M, Michalkova R, Mirossay L, Mojzisova G, Zigova M, Bardelcikova A, Mojzis J. Ellagic acid and cancer hallmarks: Insights from experimental evidence. Biomolecules. 2023 Nov;13(11):1653. Go to original source... Go to PubMed...
    10. Coutinho L, Oliveira H, Pacheco AR, Almeida L, Pimental F, Santos C, Ferreira de Oliveira JM. Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma. DNA Repair (Amst). 2017 Feb;50:36-42. Go to original source... Go to PubMed...
    11. Day TW, Wu CH, Safa AR. Etoposide induces protein kinase C delta- and caspase-3-dependent apoptosis in neuroblastoma cancer cells. Mol Pharmacol. 2009 Sep;76(3):632-40. Go to original source... Go to PubMed...
    12. Deveraux QL, Reed JC. IAP family proteins - Suppressors of apoptosis. Genes Dev. 1999 Feb 1;13(3):239-52. Go to original source... Go to PubMed...
    13. Fang Y, Zhou H, Xia JF, Lin JJ, Li RZ, Yang DQ, Xu MY, Li XY. Ellagic acid regulates Wnt/β-catenin signaling pathway and CDK8 in HCT 116 and HT 29 colon cancer cells. Bangladesh J Pharmacol. 2015 Jan;10:47-56. Go to original source...
    14. Ferreira de Oliveira JMP, Pacheco AR, Coutinho L, Oliveira H, Pinho S, Almeida L, Fernandes E, Santos C. Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models. Arch Toxicol. 2018 Mar;92(3):1205-14. Go to original source... Go to PubMed...
    15. Flory AB, Rassnick KM, Balkman CE, Kiselow MA, Autio K, Beaulieu BB, Lewis LD. Oral bioavailability of etoposide after administration of a single dose to tumor-bearing dogs. Am J Vet Res. 2008 Oct;69(10):1316-22. Go to original source... Go to PubMed...
    16. Forest V, Peoch M, Campos L, Guyotat D, Vergnon JM. Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice. Cryobiology. 2005 Feb;50(1):29-37. Go to original source... Go to PubMed...
    17. Ghavami G, Kiasari RE, Pakzad F, Sardari S. Effect of metformin alone and in combination with etoposide and epirubicin on proliferation, apoptosis, necrosis, and migration of B-CPAP and SW cells as thyroid cancer cell lines. Res Pharm Sci. 2023 Jan;18(2):185-201. Go to original source... Go to PubMed...
    18. Gong T, Su X, Xia Q, Wang J, Kan S. Expression of NF-κβ and PTEN in osteosarcoma and its clinical significance. Oncol Lett. 2017 Dec;14(6):6744-8. Go to original source... Go to PubMed...
    19. Gordon EM, Ravicz JR, Liu S, Chawla SP, Hall FL. Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologists. Mol Clin Oncol. 2018 Aug;9(2):115-34. Go to original source... Go to PubMed...
    20. Han DH, Lee MJ, Kim JH. Antioxidant and apoptosis-inducing activities of ellagic acid. Anticancer Res. 2006 Sep-Oct;26(5A):3601-6.
    21. Hohenhaus AE, Matus RE. Etoposide (VP-16). Retrospective analysis of treatment in 13 dogs with lymphoma. J Vet Intern Med. 1990 Sep-Oct;4(5):239-41. Go to original source... Go to PubMed...
    22. Jaiswal PK, Goel A, Mittal RD. Survivin: A molecular biomarker in cancer. Indian J Med Res. 2015 Apr;141(4):389-97. Go to original source... Go to PubMed...
    23. Jamil S, Lam I, Majd M, Tsai SH, Duronio V. Etoposide induces cell death via mitochondrial-dependent actions of p53. Cancer Cell Int. 2015 Aug 7;15:79. Go to original source... Go to PubMed...
    24. Jan R, Chaudhry GE. Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Adv Pharm Bull. 2019 Jun;9(2):205-18. Go to original source... Go to PubMed...
    25. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther. 2005 Feb;4(2):139-63. Go to original source... Go to PubMed...
    26. Kasibhatla S, Amarante-Mendes GP, Finucane D, Brunner T, Bossy-Wetzel E, Green DR. Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. CSH Protoc. 2006 Aug 1;2006(3):pdb.prot4493. Go to original source... Go to PubMed...
    27. Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res. 2000 Apr 10;256(1):42-9. Go to original source... Go to PubMed...
    28. Kim SS, Wengier DL, Ragland CJ, Sattely ES. Transcriptional reactivation of lignin biosynthesis for the heterologous production of etoposide aglycone in nicotiana benthamiana. ACS Synth Biol. 2022 Oct 21;11(10):3379-87. Go to original source... Go to PubMed...
    29. Lana S, U'ren L, Plaza S, Elmslie R, Gustafson D, Morley P, Dow S. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs. J Vet Intern Med. 2007 Jul-Aug;21(4):764-9. Go to original source...
    30. Larrosa M, Tomas-Barberan FA, Espin JC. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem. 2006 Sep;17(9):611-25. Go to original source... Go to PubMed...
    31. Le Deley MC, Guinebretiere JM, Gentet JC, Pacquement H, Pichon F, Marec-Berard P, Entz-Werle N, Schmitt C, Brugieres L, Vanel D, Dupouy N, Tabone MD, Kalifa C; Societe Française d'Oncologie Pediatrique (SFOP). SFOP OS94: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. Eur J Cancer. 2007 Mar;43(4):752-61. Go to original source... Go to PubMed...
    32. Li TM, Chen GW, Su CC, Lin JG, Yeh CC, Cheng KC, Chung JG. Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res. 2005 Mar-Apr;25(2A):971-9.
    33. Li R, Ruan Q, Zheng J, Zhang B, Yang H. LINC01116 promotes doxorubicin resistance in osteosarcoma by epigenetically silencing miR-424-5p and inducing epithelial-mesenchymal transition. Front Pharmacol. 2021 Mar 8;12:632206. Go to original source... Go to PubMed...
    34. Lin CF, Chen CL, Chang WT, Jan MS, Hsu LJ, Wu RH, Tang MJ, Chang WC, Lin YS. Sequential caspase-2 and caspase-8 activation upstream of mitochondria during ceramideand etoposide-induced apoptosis. J Biol Chem. 2004 Sep 24;279(39):40755-61. Go to original source... Go to PubMed...
    35. Liu Q, Liang X, Niu C, Wang X. Ellagic acid promotes A549 cell apoptosis via regulating the phosphoinositide 3-kinase/protein kinase B pathway. Exp Ther Med. 2018 Jul;16(1):347-52. Go to original source... Go to PubMed...
    36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402-8. Go to original source... Go to PubMed...
    37. Losso JN, Bansode RR, Trappey A 2nd, Bawadi HA, Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem. 2004 Nov;15(11):672-8. Go to original source... Go to PubMed...
    38. Lu Y, Li F, Xu T, Sun J. Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κβ signaling. Int J Mol Med. 2017 Apr;39(4):993-1000. Go to original source... Go to PubMed...
    39. Ludwig L, Edson M, Treleaven H, Viloria-Petit AM, Mutsaers AJ, Moorehead R, Foster RA, Ali A, Wood RD, Wood GA. Plasma microRNA signatures predict prognosis in canine osteosarcoma patients. PLoS One. 2024 Dec 31;19(12):e0311104. Go to original source... Go to PubMed...
    40. Mahbub AA, Le Maitre CL, Haywood-Small SL, Cross NA, Jordan-Mahy N. Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines. Cell Death Discov. 2015 Nov 23:1:15043. Go to original source... Go to PubMed...
    41. Marwan AG, Nagel CW. Characterization of cranberry benzoates and their antimicrobial properties. J Food Sci. 1986 Jul;51:1069-70. Go to original source...
    42. Mertens-Talcott SU, Lee JH, Percival SS, Talcott ST. Induction of cell death in Caco-2 human colon carcinoma cells by ellagic acid rich fractions from muscadine grapes (Vitis rotundifolia). J Agric Food Chem. 2006 Jul 26;54(15):5336-43. Go to original source... Go to PubMed...
    43. Montecucco A, Zanetta F, Biamonti G. Molecular mechanisms of etoposide. EXCLI J. 2015 Jan 19;14:95-108.
    44. Morello E, Martano M, Buracco P. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma. Vet J. 2011 Sep;189(3):268-77. Go to original source... Go to PubMed...
    45. Naiki-Ito A, Chewonarin T, Tang M, Pitchakarn P, Kuno T, Ogawa K, Asamoto M, Shirai T, Takahashi S. Ellagic acid, a component of pomegranate fruit juice, suppresses androgen-dependent prostate carcinogenesis via induction of apoptosis. Prostate. 2015 Feb;75(2):151-60. Go to original source... Go to PubMed...
    46. O'Kane GM, Cadoo KA, Walsh EM, Emerson R, Dervan P, O'Keane C, Hurson B, O'Toole G, Dudeney S, Kavanagh E, Eustace S, Carney DN. Perioperative chemotherapy in the treatment of osteosarcoma: A 26-year single institution review. Clin Sarcoma Res. 2015 Jul 14;5:17. Go to original source... Go to PubMed...
    47. Ong SM, Saeki K, Tanaka Y, Nishimura R, Nakagawa T. Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines. Vet J. 2016 Dec;218:51-9. Go to original source... Go to PubMed...
    48. Ong SM, Saeki K, Kok MK, Tanaka Y, Choisunirachon N, Yoshitake R, Nishimura R, Nakagawa T. Anti-tumour efficacy of etoposide alone and in combination with piroxicam against canine osteosarcoma in a xenograft model. Res Vet Sci. 2017a Aug;113:130-5. Go to original source... Go to PubMed...
    49. Ong SM, Yamamoto H, Saeki K, Tanaka Y, Yoshitake R, Nishimura R, Nakagawa T. Anti-neoplastic effects of topoisomerase inhibitors in canine mammary carcinoma, melanoma, and osteosarcoma cell lines. Jpn J Vet Res. 2017b Feb;65(1):17-28.
    50. Ong SM, Saeki K, Kok MK, Nakagawa T, Nishimura R. YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells. J Vet Med Sci. 2019 Aug 24;81(8):1182-90. Go to original source... Go to PubMed...
    51. Poon AC, Matsuyama A, Mutsaers AJ. Recent and current clinical trials in canine appendicular osteosarcoma. Can Vet J. 2020 Mar;61(3):301-8.
    52. Poradowski D, Obminska-Mrukowicz B. Effect of selected nonsteroidal anti-inflammatory drugs on the viability of canine osteosarcoma cells of the D-17 line: In vitro studies. J Vet Res. 2019 Sep 13;63(3):399-403. Go to original source... Go to PubMed...
    53. Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE. Intensified chemotherapy with dexrazoxane cardioprotection in newly diagnosed nonmetastatic osteosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2016 Jan;63(1):54-61. Go to original source... Go to PubMed...
    54. Shakeri A, Zirak MR, Sahebkar A. Ellagic acid: A logical lead for drug development? Curr Pharm Des. 2018;24(2):106-22. Go to original source... Go to PubMed...
    55. Shoeneman JK, Ehrhart EJ 3rd, Eickhoff JC, Charles JB, Powers BE, Thamm DH. Expression and function of survivin in canine osteosarcoma. Cancer Res. 2012 Jan 1;72(1):249-59. Go to original source... Go to PubMed...
    56. Uchide T, Takatsu N, Fujimori Y, Fukushima U, Itoh H. Expression of survivin mRNA in dog tumors. DNA Seq. 2005 Oct;16(5):329-34. Go to original source... Go to PubMed...
    57. Wang P, Song JH, Song DK, Zhang J, Hao C. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. Cell Signal. 2006 Sep;18(9):1528-35. Go to original source... Go to PubMed...
    58. Wang D, Chen Q, Tan Y, Liu B, Liu C. Ellagic acid inhibits human glioblastoma growth in vitro and in vivo. Oncol Rep. 2017 Feb;37(2):1084-92. Go to original source... Go to PubMed...
    59. Wilson-Robles H, Franks K, Pool R, Miller T. Characterization of five newly derived canine osteosarcoma cell lines. BMC Vet Res. 2019 Oct 22;15(1):357. Go to original source... Go to PubMed...
    60. Wright T, Brisson BA, Wood GA, Oblak M, Mutsaers AJ, Sabine V, Skowronski K, Belanger C, Tiessen A, Bienzle D. Flow cytometric detection of circulating osteosarcoma cells in dogs. Cytometry A. 2019 Sep;95(9):997-1007. Go to original source... Go to PubMed...
    61. Xu W, Xu J, Wang T, Liu W, Wei H, Yang X, Yan W, Zhou W, Xiao J. Ellagic acid and Sennoside B inhibit osteosarcoma cell migration, invasion and growth by repressing the expression of c-Jun. Oncol Lett. 2018 Jul;16(1):898-904. Go to original source... Go to PubMed...
    62. Yousef AI, El-Masry OS, Abdel Mohsen MA. Impact of cellular genetic make-up on colorectal cancer cell lines response to ellagic acid: Implications of small interfering RNA. Asian Pac J Cancer Prev. 2016;17(2):743-8. Go to original source... Go to PubMed...
    63. Yu X, Xu T, Su B, Zhou J, Xu B, Zhang Y, Zhu Y, Jiang N, He Z. The novel role of etoposide in inhibiting the migration and proliferation of small cell lung cancer and breast cancer via targeting Daam1. Biochem Pharmacol. 2023 Apr;210:115468. Go to original source... Go to PubMed...
    64. Zhang HM, Zhao L, Li H, Xu H, Chen WW, Tao L. Research progress on the anticarcinogenic actions and mechanisms of ellagic acid. Cancer Biol Med. 2014 Jun;11(2):92-100.
    65. Zhao M, Tang SN, Marsh JL, Shankar S, Srivastava RK. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice. Cancer Lett. 2013 Sep 1;337(2):210-7. Go to original source... Go to PubMed...
    66. Zhao J, Li G, Wei J, Dang S, Yu X, Ding L, Shang C, Zhang H, Zhang Z, Chen H, Liu M. Ellagic acid induces cell cycle arrest and apoptosis via the TGFβ1/Smad3 signaling pathway in human colon cancer HCT116 cells. Oncol Rep. 2020 Aug;44(2):768-76. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content